Neuroleptic Malignant Syndrome
NEJM 391:1130-1138, Wijdicks,E.F.M. & Ropper,A.H., 2024
Disorders of the Nervous System Caused by Drugs, Toxins, and Chemical Agents, Antipsychosis Drugs
Adams & Victors Principles of Neurology Chp 43, pg 1208, Ropper, A.H.,et al, 2014
Movement Disorders Emergencies Part 1
, Robottom, B.J., et al, 2011
Psychiatric Emergencies, The Neuroleptic Malignant and Serotonin Syndromes
Emerg Med Clin North Am 18:317-325, Carbone,J.R., 2000
Tolcapone for Parkinson's Disease
The Medical Letter 40:60-61, , 1998
Acute, Drug-Induced, Life-Threatening Neurological Syndromes
The Neurologist 4:196-210, Richard,I.H., 1998
Neuroleptic Malignant Syndrome
JNNP 58:271-273, Buckley,P.F.&Hutchinson,M., 1995
The Nondystrophic Myotonias
In Myology, McGraw-Hill, 2nd Ed, Ch49, p1291-13024., Rudel,R.,et al, 1994
Hyperthermia and Heatstroke
Hospital Practice 29:65-68, 73, 78-80994., Simon,H.B., 1994
Neuroleptic-Induced Catatonia as a Stage in the Progression Toward NMS
J Am Acad Child Adolesc Psychiatry 31:1161-1164, Woodbury,M.M.&Woodbury,M.A., 1992
Neuroleptic Malignant Syndrome, Review of Response to Therapy
Arch Int Med 149:1927-1931, Rosenberg,M.R.&Green,M., 1989
Successful Treatment of Neuroleptic Malignant Syndrome with Sodium Nitroprusside
Ann Int Med 104:56-57, Blue,M.G.,et al, 1986
The Neuroleptic Malignant Syndrome:Agent and Host Interaction
Acta Psychiatr Scand 73:337-347, Shaley,A.&Munitz,H., 1986
Neuroleptic Malignant Syndrome
NEJM 313:163-166, Guze,B.H.,et al, 1985
Neuroleptic Malignant Syndrome, Successful Treatment with Pancuronium
JAMA 254:2795-2796, Sangal,R.&Dimitrijevic,R., 1985
Neuroleptic Malignant Syndrome
Lancet 1:545-546, Smego,R.A.,et al, 1984
Beneficial Effects of Dantrolene in the Treatment of Neuroleptic Malignant Syndrome:A Report of Two Cases
Neurol 33:516-518, Goulon,M.,et al, 1983
Neuroleptic Malignant Syndrome:Successful Treatment with Dantolene & Bromocriptine
Ann Neurol 14:89-90, Granato,J.E.,et al, 1983
Neuroleptic Malignant Syndrome, Successful Treatment with Bromocriptine
JAMA 249:386-388, Mueller,P.S.,et al, 1983
Clinical Manifestations of Primary CNS T-Cell Lymphoma, Retrospective Study of Histopathologic, Molecular, and Neuroimaging Fetures
Neurol 106:e24744, Muller,K.J.,et al, 2026
Real-World Evidence of Brexpiprazole Use and 6-Month Mortality, Hospitalization, and Emergency Department Visits Among Persons with Dementia
Neurol 105: e213717, Zissimopoulos, J.,et al, 2025
Clinicopathologic conference, Malignant Mixed Germ-Cell Tumor and Anti-NMDA Receptor Encephalitis
NEJM 303:488-496, Case 22-2025, 2025
Frequency, Risk Factors, and Outcomes of Strokes in Patients with Primary Glioma After Cranial Radiation
Neurol 105:e213902, Ryan,D.,et al, 2025
Surgical Management of ICH:Past, Present, and Future Prospects
Stroke 56:e355-358, Tarek,M.A.,et al, 2025
Granulomatosis with Polyangiitis Presenting as Isolated Ear Involvement A Case Series and Literature Review
ACTA Otorhinolaryngol Italica 45:217-230, Zorzi,S.,et al, 2025
Cavernous Sinus Thrombosis
Stat Pearls June 16, Plewa,M.C. & Hall, W.A., 2025
Paraneoplastic Calmodulin Kinase-Like Vesicle-Associated Protein (CAMKV) Autoimmune Encephalitis
Ann Neurol 96:21-33, Gilligan,M.,et al, 2024
Parkinsons Disease
NEJM 391:442-452, Tanner,C.M. & Ostrem,J.L., 2024
Surgical Management for Primary Intracerebral Hemorrhage
Neurol 103::e209714, Morris,N.A.,et al, 2024
Clinical Presentation, Management, and Outcome in Neurolymphomatosis, A Systematic Review
Neurol 103:e209698, Kaulen.L.D.,et al, 2024
Intracranial Involvement of Systemic Hodgkin Lymphoma:A Case Report and Literature Review
Brain Tumor Res Treat 12:63-69, Lee,H.,et al, 2024
A 66-Year-Old Woman With Progressive Encephalopathy and Bilateral Hearing Loss
Neurol 100:254-258, Rivers,D.,et al, 2023
Primary Diffuse Leptomeningeal Melanocytosis, A Diagnoatic Conundrum
Neurol 101:e576-3580, Selvarajan,J.M.P.,et al, 2023
Management and Long-term Outcomes of Adults With Medulloblastoma, A Single-Center Experience
Neurol 101:e1256-e1271, Neth,B.J.,et al, 2023
Primary Brain Tumours in Adults
Lancet 402:1564-1579, van den Bent,M.,et al, 2023
Surgical Decompression for Malignant Cerebral Edema After Ischemic Stroke:Cochrane Review
Stroke 54:e500-5502, Dower,A.,et al, 2023
Brexpiprazole for the Treatment of Agitation and Aggression in Alzheimers Disease
JAMA Neurol 80:1272-1273, Ballard,C., 2023
Acute Myelopathy in a Man with Cutaneous Papules
JAMA Neurol 79:84-85, Neo, S.,et al, 2022
Confused About Confusion
NEJM 386:80-87, Spanjaart, A.M.,et al, 2022
Clinicopathologic Conference, Diffuse Large B-Cell Lymphoma
NEJM 386:977-986, Case 7-2022, 2022
Brain Tumors in Children
NEJM 386:1922-1931, Cohen, A.R., 2022
Ethical Considerations in Surgical Decompression for Stroke
Stroke 53:2676-2682, Shlobin, N.A.,et al, 2022
Neuromyelitis Optica Spectrum Disorder
NEJM 387:631-639, Wingerchuk, D.M. & Lucchinetti, C.F., 2022
In Patients with Melanoma Brain Metastases, is Combination Immune Checkpoint Inhibition a Safe and Effective First-Line Treatment? A Critically Appraised Topic
Neurologist 27:290-297, Gritsch, D.,et al, 2022
Spontaneous Intracerebral Hemorrhage
NEJM 387:1589-1596, Sheth, K.N., 2022
Paraneoplastic Myeloneuropathies
Neurol 96:e632-e639, Shah, S.,et al, 2021
Clinicopathologic Conference, Lympohplasmic Lymphoma of the CNS (Bing-Neel Syndrome)
NEJM 384:745-753, Case 6-2021, 2021
Case Report: Anti-NMDA Receptor Encephalitis with Bilateral Hearing Loss as the Initial Symptom
Front Neurol doi:10.3389/FNEUR.2021.648911, Cheng,H.,et al, 2021
Management and Outcome of Primary CNS Lymphoma in the Modern Era
Neurol 94:e1027-e1039, Houillier, C., et al, 2020